¿Quiénes somos?

About us

   

Ascires is Spain’s leading biomedical group in Genetics, Diagnostic Imaging and Nuclear Medicine

 

About Ascires Biomedical Group

By volume of medical technology, we are Spain’s pioneering biomedical group in Genetics, Diagnostic Imaging and Nuclear Medicine, as well as a benchmark in Radiation Oncology.

With Mediterranean roots, Ascires group develops its activity in its network of Biomedical Clinics in the Valencian Community and Catalonia (Cetir Ascires), as well as for public and private hospitals.

With over 50 years of experience, Ascires reinvest an average of 15% of its profits in R+D+i. An investment effort that allows us to incorporate the latest advances in precision medicine, with continuous innovation in the development of artificial intelligence biomarkers and diagnostic algorithms, which integrate genomic, clinical and diagnostic imaging data.

 

 

Our Story

Development of the aDELAIDE project, in collaboration with the Medexprim company, which, through Big Data technologies, allows searching for and unifying medical image information with data from clinical reports.

 

Ascires incorporates the only open Magnetic Resonance in Valencia.

Ascires, with the support of the Valencian Innovation Agency, creates a digital twin of the aorta for greater precision in the diagnosis and prognosis of heart disease.

Ascires Sistemas Genómicos develops a new PCR that identifies the main variants of COVID

Ascires Sistemas Genómicos launches its own PCR genetic test for the COVID detection

Ascires develops the first bioinformatics platform aimed at the diagnosis and control
of SARS-CoV-2.

Introduction to the Valencian Community of the first MR-guided Neuro-HIFU treatment.

AsciresTools: Artificial Intelligence applied to medical imaging to maximize diagnostic accuracy.

Ascires, pioneers in the incorporation of PET/MRI in Spain.

ECG, Médica S.L. optimizes treatment in radiotherapy oncology using the Bolus 3D application.

Birth of Ascires

ECG Médica, S.L. and CETIR introduce  HIFU technology for essential tremor.

Sistemas Genómicos obtains CLIA-USA certification. It also registers the first product with CE marking (next-generation sequencing kits).

ECG Médica makes the first High-Definition CT machine with spectral imaging in Spain..

Merger of CETIR and ECG Médica

ECG Médica S.L. offers the first service in Spain in the use of Image Guided Radiotherapy (IGRT) to improve the precision of radiation
in tumors.

Sistemas Genómicos is a pioneer in the use of massive sequencing for diagnosis.

ECG Médica S.L. offers the first service in Spain of Image Guided Radiotherapy (IGRT) to improve the accuracy of radiation in tumors.

ECG Médica, S.L. is a pioneer in Europe in the use of Intensity-Modulated Radiotherapy (IMRT) for the treatment of cancer.

  • Cetir crea la Unidad de Investigación en Neuroimagen.

ECG Médica S.L. is a pioneer in Europe in the use of Intensity-Modulated Radiotherapy (IMRT) for the treatment of cancer.

 

 

ECG Médica, SL. incorporates the first Valencian Community Digital Linear Accelerator for Radiotherapy.

CETIR obtains ISO certification for all Care Services.

Foundation of Sistemas Genómicos (1998)

CETIR was a pioneer with the first Magnetic Resonance Imaging machine in Spain.

CETIR was a pioneer with the first Magnetic Resonance Imaging machine in Spain.

CETIR was a pioneer with the first Magnetic Resonance Imaging machine in Spain.

Birth of the Radiological Group, the forerunner of ECG Médica in Valencia.

ECG Médica, S.L. was one of the first to install a CT machine in Spain.

Birth of CETIR in Catalonia.